G. Biolcatti, S. Hanneken, E. I. Minder, N. J. Neumann, J. H. P. Wilson, P. J. Wolgen, . . . A. J. Lloyd. (2021). Validation of a novel patient reported tool to assess the impact of treatment in erythropoietic protoporphyria: The EPP-QoL. SpringerOpen.
Chicago Style (17th ed.) CitationG. Biolcatti, S. Hanneken, E. I. Minder, N. J. Neumann, J. H. P. Wilson, P. J. Wolgen, D. J. Wright, and A. J. Lloyd. Validation of a Novel Patient Reported Tool to Assess the Impact of Treatment in Erythropoietic Protoporphyria: The EPP-QoL. SpringerOpen, 2021.
MLA (9th ed.) CitationG. Biolcatti, et al. Validation of a Novel Patient Reported Tool to Assess the Impact of Treatment in Erythropoietic Protoporphyria: The EPP-QoL. SpringerOpen, 2021.
Warning: These citations may not always be 100% accurate.